Gyre Therapeutics, Inc.GYRENASDAQ
Loading
Gross Profit Over TimeStrong
Percentile Rank100
3Y CAGR+4.5%
5Y CAGR+56.7%
Studio
Year-over-Year Change

Revenue minus cost of goods sold

3Y CAGR
+4.5%/yr
Annual compound
5Y CAGR
+56.7%/yr
Recent deceleration
Percentile
P100
Near historical high
vs 5Y Ago
9.4x
Strong expansion
Streak
1 yr
Consecutive growthStrong
PeriodValueYoY Change
TTM$111.17M+9.1%
2024$101.87M-6.4%
2023$108.81M+11.6%
2022$97.50M+29466.6%
2021$-332000.00-102.8%
2020$11.79M+8171.9%
2019$-146000.00+99.3%
2018$-21.47M-81.5%
2017$-11.83M-16.5%
2016$-10.16M-